The increasing focus on cervical cancer prevention is driving demand for HPV testing, but the market also faces several challenges. Limited screening awareness in low- and middle-income countries, high costs associated with advanced molecular diagnostic tests, and disparities in laboratory infrastructure can restrict access to timely diagnosis. Social stigma surrounding sexually...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek